# US 2024/0189320 A1 · Highly active sting protein agonist compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189320 A1
- Document ID: US20240189320A1
- Status: Published application
- Kind: A1
- Application number: 17/270,480
- Filed: 2019-08-22
- Published: 2024-06-13
- Earliest claimed: 2018-08-29
- Assignees: Adlai Nortye Biopharma Co., Ltd.
- Applicants: Adlai Nortye Biopharma Co., Ltd.
- Inventors: Yufeng CHEN; Kaixuan CHEN; Pan LI; Canfeng LIU; Ji WANG; Qingchong QIU; Yang LU
- Web page: https://patentgrep.com/patent/US20240189320A1

## CPC

- A61K 31/5386: spiro-condensed or forming part of bridged ring systems
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 31/437: the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A61K 31/4985: Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A61K 31/5383: ortho- or peri-condensed with heterocyclic ring systems
- A61K 31/541: Non-condensed thiazines containing further heterocyclic rings
- A61K 31/551: having two nitrogen atoms, e.g. dilazep
- A61K 31/553: having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A61K 31/675: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A61P 31/08: for leprosy
- A61P 35/00: Antineoplastic agents
- C07D 471/06: Peri-condensed systems
- C07D 487/06: Peri-condensed systems
- C07D 498/06: Peri-condensed systems
- C07D 498/22: in which the condensed system contains four or more hetero rings
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention provides compounds of Formula (I) or (II), pharmaceutical compositions thereof, and methods of using compounds of Formula (I) or (II) to prevent and/or treat immune-related disorders.

## Claims

### Claim 1

A compound having a structure of Formula (I) or (II),
wherein W1 represents (CRaRa′)s, any one CRaRa′ is optionally substituted by 0, 1 or 2 O, S or NRb, or any one CRaRa′ is optionally taken together to form —C═O;
W2 represents (CRhRh′)t, wherein any one CRhRh′ is optionally substituted by 0, 1 or 2 O, S or NRj, or any one CRhRh′ is optionally taken together to form —C═O;
s and t each independently consist of an integer selected from 1, 2, and 3;
q is selected from 0 and 1;
r is selected from 0 and 1; and
q and r are not 0 at the same time;
wherein R1, R2, R3, and R4 each independently represent hydrogen, halogen, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —ORc, —O—(C1-C6 alkylene)-NRcRc′, —NRcRc′, —OC(O)Rc, —C(O)Rc, —CO2R, —CON(Rc)(Rc′), —C(═NH)N(Rc)(Rc′), —NRcC(O)Rc′, —SO2Rc, —SO2NRcRc′, —N(Rc)—SO2—(C1-C6 alkyl)-NRcRc′, —N(Rc)—C(O)—(C1-C6 alkyl)-NRcRc′, —NRcS(O)Rc′, —NRcSO2Rc′, —O—P(O)(ORc)(ORc′), 6- to 12-membered aryl or 5- to 12-membered heteroaryl;
R5 and R6 are each independently selected from hydrogen or C1-C6 alkyl;
wherein when q=0, QA1 is each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl); or QA1 and R5 together with atoms adjacent thereto form a 3- to 6-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S; QA2 is each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl); or QA2 and R6 together with atoms adjacent thereto, form a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N, and S;
when q=1, -QA1-A-QA2- is taken together to form a linking group selected from: —C1-C6 alkylene-, —C2-C6 alkenylene-, —C2-C6 alkynylene-, —(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—(C0-C6 alkylene)-, —C(O)—(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-OC(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—C(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)O—(C0-C6 alkylene)-, -(C0-C6 alkylene)-(C3-C6 carbocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(6- to 12-membered aryl)-(C0-C6 alkylene)-, and —(C0-C6 alkylene)-(5- to 12-membered heteroaryl)-(C0-C6 alkylene)-;
wherein when r=0, QB1 and QB2 are each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl);
when r=1, -QB1-B-QB2- is taken together to form a linking group selected from: —C1-C6 alkylene-, —C2-C6 alkenylene-, —C2-C6 alkynylene-, —(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—(C0-C6 alkylene)-, —C(O)—(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-OC(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—C(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)O—(C0-C6 alkylene)-, -(C0-C6 alkylene)-(C3-C6 carbocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(6- to 12-membered aryl)-(C0-C6 alkylene)-, and —(C0-C6 alkylene)-(5- to 12-membered heteroaryl)-(C0-C6 alkylene)-;
RI and RII each independently represent hydrogen or C1-C6 alkyl;
wherein Ra, Ra′, Rh and Rh′ each independently represent hydrogen, halogen, hydroxy, C1-C6 alkyl, C1-C6 alkylthio, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl), —(C0-C6 alkylene)-(6- to 12-membered aryl), —(C0-C6 alkylene)-(5- to 12-membered heteroaryl), —NRdRd′, —NRdCORd′, —NRdS(O)Rd′, —NRdSO2Rd′, —ORd, or —OCORd;
Rb and Rj each independently represent hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, —(C0-C6 alkylene)-(6- to 12-membered aryl), —C(O)Re, —SORe, —SO2Re, —C(O)ORe, or —C(O)NReRe′;
Rc and Rc′ each independently represent hydrogen, C1-C6 alkyl, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), or —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl);
or Ra and Ra′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
or Rc and Rc′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
or Rh and Rh′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
wherein m=1, 2, 3 or 4;
n=1, 2 or 3;
o=1 or 2; and
p=1 or 2;
or when m=2, the two adjacent R1 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when n=2, the two adjacent R2 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when p=2, the two adjacent R4 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
any alkyl, alkoxy, alkenyl, alkynyl, alkylene, aryl, heteroaryl, carbocyclyl, heterocyclyl defined above are optionally substituted by 0, 1, 2, 3, or 4 substituents selected from:
C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORe, —C(O)—ORf, —OC(O)Rf, —S(O)Rf, —S(O)2Rf, —S(O)2NRfRf′, —OCONRfRf, —NRfCORf′, —NRfS(O) Rf′, —NRfS(O)2Rf′, —NRfC(O)ORf, —CONRfRf′, —NRfRf′, —NHC═NHNRfRf′, C1-C6 haloalkyl, C1-C6 haloalkoxy, and —O—P(O)(ORf)(ORf′);
wherein Rd, Rd′, Re, Re′, Rf, and Rf′ each independently represent hydrogen or C1-C6 alkyl, wherein the C1-C6 alkyl is also optionally substituted by C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORg, —C(O)—ORg, —OC(O)Rg, —S(O)Rg, —S(O)2Rg, —S(O)2NRgRg′, —NRgCORg′, —NRS(O) Rg′, —NRgS(O)2Rg′, —NRgC(O)ORg′, —CONRgRg′, —NRgRg′, C1-C6 haloalkyl, C1-C6 haloalkoxy, or —O—P(O)(ORg)(ORg′);
or Rd, Rd′, Re, Re′, Rf, and Rf′ together with the nitrogen atom bound thereto form a 5- to 8-membered carbocycle or a 5- to 8-membered heterocycle;
wherein Rg and Rg′ are each independently selected from hydrogen or C1-C6 alkyl.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The compound according to claim 1, having the following structure:
wherein W1 represents (CRaRa′)s, wherein any one CRaRa′ is optionally substituted by 0, 1 or 2O, S or NRb, or any one CRaRa′ is optionally taken together to form —C═O;
s is selected from integers of 1, 2 and 3;
wherein R1, R2, R3, and R4 each independently represent hydrogen, halogen, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —ORc, —O—(C1-C6 alkylene)-NRcRc′, —NRcRc′, —OC(O)Rc, —C(O)Rc, —CO2R, —CON(Rc)(Rc′), —C(═NH)N(Rc)(Rc′), —NRcC(O)Rc′, —SO2Rc, —SO2NRcRc′, —N(Rc)—SO2—(C1-C6 alkyl)-NRcRc′, —N(Rc)—C(O)—(C1-C6 alkyl)-NRcRc′, —NRcS(O)Rc′, —NRcSO2Rc′, —O—P(O)(ORc)(ORc′), 6- to 12-membered aryl or 5- to 12-membered heteroaryl;
R5 is selected from hydrogen or C1-C6 alkyl;
wherein -QAl-A-QA2- is taken together to form a linking group selected from: —C1-C6 alkylene-, —C2-C6 alkenylene-, —C2-C6 alkynylene-, —(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—(C0-C6 alkylene)-, —C(O)—(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-OC(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—C(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-(C3-C6 carbocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(6- to 12-membered aryl)-(C0-C6 alkylene)-, and —(C0-C6 alkylene)-(5- to 12-membered heteroaryl)-(C0-C6 alkylene)-;
QB1 and QB2 are each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl);
RI and RII each independently represent hydrogen or C1-C6 alkyl;
wherein Ra and Ra′ each independently represent hydrogen, halogen, hydroxy, C1-C6 alkyl, C1-C6 alkylthio, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl), —(C0-C6 alkylene)-(6- to 12-membered aryl), —(C0-C6 alkylene)-(5- to 12-membered heteroaryl), —NRdRd′, —NRdCORd′, —NRdS(O)Rd′, —NRdSO2Rd′, —ORd, or —OCORd;
Rb each independently represents hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, —(C0-C6 alkylene)-(6- to 12-membered aryl), —C(O)Re, —SORe, —SO2Re, —C(O)ORe, or —C(O)NReRe′;
Rc and Rc′ each independently represent hydrogen, C1-C6 alkyl, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), or —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl);
or Ra and Ra′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
or Rc and Rc′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
wherein m=1, 2, 3 or 4;
n=1, 2 or 3;
o=1 or 2; and
p=1 or 2;
or when m=2, the two adjacent R1 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when n=2, the two adjacent R2 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when p=2, the two adjacent R4 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
any alkyl, alkoxy, alkenyl, alkynyl, alkylene, aryl, heteroaryl, carbocyclyl, heterocyclyl defined above are optionally substituted by 0, 1, 2, 3, or 4 substituents selected from:
C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORf, —C(O)—ORf, —OC(O)Rf, —S(O)Rf, —S(O)2Rf, —S(O)2NRfRf, —OCONRfRf′, —NRfCORf′, —NRfS(O) Rf′, —NRfS(O)2Rf′, —NRfC(O)ORf′, —CONRfRf′, —NRfRf′, —NHC═NHNRfRf′, C1-C6 haloalkyl, C1-C6 haloalkoxy, and —O—P(O)(ORf)(ORf′);
wherein Rd, Rd′, Re, Re′, Rf, and Rf′ each independently represent hydrogen or C1-C6 alkyl, wherein the C1-C6 alkyl is also optionally substituted by C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORg, —C(O)—ORg, —OC(O)Rg, —S(O)Rg, —S(O)2Rg, —S(O)2NRgRg′, —NRgCORg′, —NRgS(O) Rg′, —NRgS(O)2Rg′, —NRgC(O)ORg′, —CONRgRg′, —NRgRg′, C1-C6 haloalkyl, C1-C6 haloalkoxy, or —O—P(O)(ORg)(ORg′);
or Rd, Rd′, Re, Re′, Rf, and Rf′ together with the nitrogen atom bound thereto form a 5- to 8-membered carbocycle or a 5- to 8-membered heterocycle;
wherein Rg and Rg′ are each independently selected from hydrogen or C1-C6 alkyl.

### Claim 4 (depends on 1)

The compound according to claim 1, having the following structure:
wherein W1 represents (CRaRa′)s, wherein any one CRaRa′ is optionally substituted by 0, 1 or 2 O, S or NRb, or any one CRaRa′ is optionally taken together to form —C═O;
W2 represents (CRhRh′)t, wherein any one CRhRh′ is optionally substituted by 0, 1 or 2O, S or NRj, or any one CRhRh′ is optionally taken together to form —C═O;
s and t each independently consist of an integer selected from 1, 2, and 3;
wherein R1, R2, R3, and R4 each independently represent hydrogen, halogen, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —ORc, —O—(C1-C6 alkylene)-NRcRc′, —NRcRc′, —OC(O)Rc, —C(O)Rc, —CO2R, —CON(Rc)(Rc′), —C(═NH)N(Rc)(Rc′), —NRcC(O)Rc′, —SO2Rc, —SO2NRcRc′, —N(Rc)—SO2—(C1-C6 alkyl)-NRcRc′, —N(Rc)—C(O)—(C1-C6 alkyl)-NRcRc′, —NRcS(O)Rc′, —NRcSO2Rc′, —O—P(O)(ORc)(ORc′), 6- to 12-membered aryl, or 5- to 12-membered heteroaryl;
R5 and R6 are each independently selected from hydrogen or C1-C6 alkyl;
wherein -QA1-A-QA2- is taken together to form a linking group selected from: —C1-C6 alkylene-, —C2-C6 alkenylene-, —C2-C6 alkynylene-, —(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—(C0-C6 alkylene)-, —C(O)—(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-OC(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—C(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-(C3-C6 carbocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(6- to 12-membered aryl)-(C0-C6 alkylene)-, and —(C0-C6 alkylene)-(5- to 12-membered heteroaryl)-(C0-C6 alkylene)-;
QB1 and QB2 are each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl);
RI and RII each independently represent hydrogen or C1-C6 alkyl;
wherein Ra, Ra′, Rh, and Rh′ each independently represent hydrogen, halogen, hydroxy, C1-C6 alkyl, C1-C6 alkylthio, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl), —(C0-C6 alkylene)-(6- to 12-membered aryl), —(C0-C6 alkylene)-(5- to 12-membered heteroaryl), —NRdRd′, —NRdCORd′, —NRdS(O)Rd′, —NRdSO2Rd′, —ORd, or —OCORd;
Rb and Rj each independently represent hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, —(C0-C6 alkylene)-(6-to 12-membered aryl), —C(O)Re, —SORe, —SO2Re, —C(O)ORe, or —C(O)NReRe′;
Rc and Rc′ each independently represent hydrogen, C1-C6 alkyl, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), or —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl);
or Ra and Ra′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
or Rc and Rc′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
or Rh and Rh′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
wherein m=1, 2, 3 or 4;
n=1, 2 or 3;
o=1 or 2; and
p=1 or 2;
or when m=2, the two adjacent R1 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when n=2, the two adjacent R2 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when p=2, the two adjacent R4 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
any alkyl, alkoxy, alkenyl, alkynyl, alkylene, aryl, heteroaryl, carbocyclyl, heterocyclyl defined above are optionally substituted by 0, 1, 2, 3, or 4 substituents selected from:
C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORf, —C(O)—ORf, —OC(O)Rf, —S(O)Rf, —S(O)2Rf, —S(O)2NRfRf, —OCONRfRf′, —NRfCORf′, —NRfS(O) Rf′, —NRfS(O)2Rf′, —NRfC(O)ORf′, —CONRfRf′, —NRfRf′, C1-C8 haloalkyl, C1-C8 haloalkoxy, and —O—P(O)(ORf)(ORf′);
wherein Rd, Rd′, Re, Re′, Rf, and Rf′ each independently represent hydrogen or C1-C6 alkyl, wherein the C1-C6 alkyl is also optionally substituted by C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORg, —C(O)—ORg, —OC(O)Rg, —S(O)Rg, —S(O)2Rg, —S(O)2NRgRg′, —NRgCORg′, —NRS(O) Rg′, —NRgS(O)2Rg′, —NRgC(O)ORg′, —CONRgRg′, —NRgRg′, C1-C6 haloalkyl, C1-C6 haloalkoxy, or —O—P(O)(ORg)(ORg′);
or Rd, Rd′, Re, Re′, Rf, and Rf′ together with the nitrogen atom bound thereto form a 5- to 8-membered carbocycle or a 5- to 8-membered heterocycle;
wherein Rg and Rg′ are each independently selected from hydrogen or C1-C6 alkyl.

### Claim 5 (depends on 1)

The compound according to claim 1, having the following structure:
wherein W1 represents (CRaRa′)s, wherein any one CRaRa′ is optionally substituted by 0, 1 or 2O, S or NRb, or any one CRaRa′ is optionally taken together to form —C═O;
s is selected from integers of 1, 2 and 3;
wherein R1, R2, R3, and R4 each independently represent hydrogen, halogen, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —ORc, —O—(C1-C6 alkylene)-NRcRc′, —NRcRc′, —OC(O)Rc, —C(O)Rc, —CO2R, —CON(Rc)(Rc′), —C(═NH)N(Rc)(Rc′), —NRcC(O)Rc′, —SO2Rc, —SO2NRcRc′, —N(Rc)—SO2—(C1-C6 alkyl)-NRcRc′, —N(Rc)—C(O)—(C1-C6 alkyl)-NRcRc′, —NRcS(O)Rc′, —NRcSO2Rc′, —O—P(O)(ORc)(ORc′), 6- to 12-membered aryl or 5- to 12-membered heteroaryl;
R5 is selected from hydrogen or C1-C6 alkyl;
wherein QA1 is each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl); or QA1 and R5 together with the atoms adjacent thereto, form a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N, and S; QA2 is each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl);
wherein -QB1-B-QB2- is taken together to form a linking group selected from: —C1-C6 alkylene-, —C2-C6 alkenylene-, —C2-C6 alkynylene-, —(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—(C0-C6 alkylene)-, —C(O)—(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-OC(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—C(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-(C3-C6 carbocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(6- to 12-membered aryl)-(C0-C6 alkylene)-, and —(C0-C6 alkylene)-(5- to 12-membered heteroaryl)-(C0-C6 alkylene)-;
RI and RII each independently represent hydrogen or C1-C6 alkyl;
wherein Ra and Ra′ each independently represent hydrogen, halogen, hydroxy, C1-C6 alkyl, C1-C6 alkylthio, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl), —(C0-C6 alkylene)-(6- to 12-membered aryl), —(C0-C6 alkylene)-(5- to 12-membered heteroaryl), —NRdRd′, —NRdCORd′, —NRdS(O)Rd′, —NRdSO2Rd′, —OR, or —OCORd;
Rb each independently represents hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, —(C0-C6 alkylene)-(6- to 12-membered aryl), —C(O)Re, -SO2Re, —SO2Re, —C(O)ORe, or —C(O)NReRe′;
Rc and Rc′ each independently represent hydrogen, C1-C6 alkyl, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), or —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl);
or Ra and Ra′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
or Rc and Rc′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
wherein m=1, 2, 3 or 4;
n=1, 2 or 3;
o=1 or 2; and
p=1 or 2;
or when m=2, the two adjacent R1 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when n=2, the two adjacent R2 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when p=2, the two adjacent R4 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
any alkyl, alkoxy, alkenyl, alkynyl, alkylene, aryl, heteroaryl, carbocyclyl, heterocyclyl defined above are optionally substituted by 0, 1, 2, 3, or 4 substituents selected from:
C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORf, —C(O)—ORf, —OC(O)Rf, —S(O)Rf, —S(O)2Rf, —S(O)2NRfRf′, —OCONRfRf′, —NRfCORf′, —NRfS(O) Rf′, —NRfS(O)2Rf′, —NRfC(O)ORf′, —CONRfRf′, —NRfRf′, —NHC═NHNRfRf′, C1-C6 haloalkyl, C1-C6 haloalkoxy, and —O—P(O)(ORf)(ORf′);
wherein Rd, Rd′, Re, Re′, Rf, and Rf′ each independently represent hydrogen or C1-C6 alkyl, wherein the C1-C6 alkyl is also optionally substituted by C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORg, —C(O)—ORg, —OC(O)Rg, —S(O)Rg, —S(O)2Rg, —S(O)2NRgRg′, —NRgCORg′, —NRgS(O) Rg′, —NRgS(O)2Rg′, —NRgC(O)ORg′, —CONRgRg′, —NRgRg′, C1-C6 haloalkyl, C1-C6 haloalkoxy, or —O—P(O)(ORg)(ORg′);
or Rd, Rd′, Re, Re′, Rf, and Rf′′together with the nitrogen atom bound thereto form a 5- to 8-membered carbocycle or a 5- to 8-membered heterocycle;
wherein Rg and Rg′ are each independently selected from hydrogen or C1-C6 alkyl.

### Claim 6 (depends on 1)

The compound according to claim 1, having the following structure:
wherein W1 represents (CRaRa′)s, wherein any one CRaRa′ is optionally substituted by 0, 1 or 2O, S or NRb, or any one CRaRa′ is optionally taken together to form —C═O;
W2 represents (CRhRh′)t, wherein any one CRhRh′ is optionally substituted by 0, 1 or 2O, S or NRj, or any one CRhRh′ is optionally taken together to form —C═O;
s and t each independently consist of an integer selected from 1, 2, and 3;
wherein R1, R2, R3, and R4 each independently represent hydrogen, halogen, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —ORc, —O—(C1-C6 alkylene)-NRcRc′, —NRcRc′, —OC(O)Rc, —C(O)Rc, —CO2R, —CON(Rc)(Rc′), —C(═NH)N(Rc)(Rc′), —NRcC(O)Rc′, —SO2Rc, —SO2NRcRc′, —N(Rc)—SO2—(C1-C6 alkyl)-NRcRc′, —N(Rc)—C(O)—(C1-C6 alkyl)-NRcRc′, —NRcS(O)Rc′, —NRcSO2Rc′, —O—P(O)(ORc)(ORc′), 6- to 12-membered aryl, or 5- to 12-membered heteroaryl;
R5 and R6 are each independently selected from hydrogen or C1-C6 alkyl;
wherein QA1 is each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl); or QA1 and R5 together with the atoms adjacent thereto, form a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N, and S; QA2 is each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —(C0-C6 alkyl)-(C3-C6 cycloalkyl), —(C0-C6 alkyl)-(4- to 6-membered heterocyclyl), —(C0-C6 alkyl)-(6- to 12-membered aryl), and —(C0-C6 alkyl)-(5- to 12-membered heteroaryl); or QA2 and R6 together with the atoms adjacent thereto, form a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N, and S;
where -QB1-B-QB2- is taken together to form a linking group selected from: —C1-C6 alkylene-, —C2-C6 alkenylene-, —C2-C6 alkynylene-, —(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—(C0-C6 alkylene)-, —C(O)—(C0-C6 alkylene)-O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-OC(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—C(O)—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)—NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-NRc—(C0-C6 alkylene)-, —(C0-C6 alkylene)-C(O)O—(C0-C6 alkylene)-, —(C0-C6 alkylene)-(C3-C6 carbocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl)-(C0-C6 alkylene)-, —(C0-C6 alkylene)-(6- to 12-membered aryl)-(C0-C6 alkylene)-, and —(C0-C6 alkylene)-(5- to 12-membered heteroaryl)-(C0-C6 alkylene)-;
RI and RII each independently represent hydrogen or C1-C6 alkyl;
wherein Ra, Ra′, Rh, and Rh′ each independently represent hydrogen, halogen, hydroxy, C1-C6 alkyl, C1-C6 alkylthio, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl), —(C0-C6 alkylene)-(6- to 12-membered aryl), —(C0-C6 alkylene)-(5- to 12-membered heteroaryl), —NRdRd′, —NRdCORd′, —NRdS(O)Rd′, —NRdSO2Rd′, —ORd, or —OCORd;
Rb and Rj each independently represent hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, —(C0-C6 alkylene)-(6-to 12-membered aryl), —C(O)Re, —SORe, —SO2Re, —C(O)ORe, or —C(O)NReRe′;
Rc and Rc′ each independently represent hydrogen, C1-C6 alkyl, —(C0-C6 alkylene)-(C3-C6 cycloalkyl), or —(C0-C6 alkylene)-(4- to 6-membered heterocyclyl);
or Ra and Ra′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
or Rc and Rc′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
or Rh and Rh′ together with the atom bound thereto are optionally cyclized to each other into a 3- to 6-membered ring optionally containing 0, 1, or 2 heteroatoms selected from O, N and S;
wherein m=1, 2, 3 or 4;
n=1, 2 or 3;
o=1 or 2; and
p=1 or 2;
or when m=2, the two adjacent R1 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when n=2, the two adjacent R2 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
or when p=2, the two adjacent R4 and the atom bound thereto are optionally cyclized to each other into a 5- to 8-membered ring optionally containing 0, 1 or 2 heteroatoms selected from O, N and S;
any alkyl, alkoxy, alkenyl, alkynyl, alkylene, aryl, heteroaryl, carbocyclyl, heterocyclyl defined above are optionally substituted by 0, 1, 2, 3, or 4 substituents selected from:
C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORf, —C(O)—ORf, —OC(O)Rf, —S(O)Rf, —S(O)2Rf, —S(O)2NRfRf, —OCONRfRf′, —NRfCORf′, —NRfS(O) Re, —NRfS(O)2Rr, —NRfC(O)ORf, —CONRfRf′, —NRfRf′, C1-C8 haloalkyl, C1-C8 haloalkoxy, and —O—P(O)(ORf)(ORe);
wherein Rd, Rd′, Re, Re′, Rf, and Rf′ each independently represent hydrogen or C1-C6 alkyl, wherein the C1-C6 alkyl is also optionally substituted by C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, sulfo, cyano, 3- to 8-membered carbocyclyl, 3- to 8-membered heterocyclyl, 6- to 12-membered aryl, 5- to 12-membered heteroaryl, nitro, oxo, C1-C6 mercapto, C1-C6 alkoxy, —ORg, —C(O)—ORg, —OC(O)Rg, —S(O)Rg, —S(O)2Rg, —S(O)2NRgRg′, —NRgCORg′, —NRS(O) Rg′, —NRgS(O)2Rg′, —NRgC(O)ORg′, —CONRgRg′, —NRgRg′, C1-C6 haloalkyl, C1-C6 haloalkoxy, or —O—P(O)(ORg)(ORg′);
or Rd, Rd′, Re, Re′, Rf, and Rf′ together with the nitrogen atom bound thereto form a 5- to 8-membered carbocycle or a 5- to 8-membered heterocycle;
wherein Rg and Rg′ are each independently selected from hydrogen or C1-C6 alkyl.

### Claim 7 (depends on 1)

The compound according to claim 1, wherein R1 and R2 are each independently selected from the group consisting of hydrogen, halogen, cyano, C1-C6 alkyl, —ORc, —O—(C1-C6 alkylene)-NRcRc′, —NRcRc′ —CON(Rc)(Rc′), —C(═NH)N(Rc)(Rc′), and —NRcC(O)Rc′.

### Claim 8 (depends on 1)

The compound according to claim 1, wherein R1 is each independently selected from: C1-C6 alkyl, C1-C6 alkoxy, —CON(Rc)(R′), —NRcRc′, —O—(C1-C6 alkylene)-NRcRc′.

### Claim 9 (depends on 1)

The compound according to claim 1, wherein R1 is each independently selected from: —O—(C1-C6 alkylene)-NRcRc′;
wherein R2 is each independently selected from: —CON(R′)(Rc′);
wherein Rc and Rc′ consist of hydrogen or C1-C6 alkyl, and are also optionally substituted by 0, 1, 2, 3 or 4 substituents selected from the group consisting of —ORd, —C(O)—ORd, —OC(O)Rd, —CONRdRd′, —NRdRd′, and —O—P(O)(ORd)(ORd′), wherein Rd and Rd′ consist of hydrogen or C1-C6 alkyl, or Rd and Rd′ together with the nitrogen atom adjacent thereto form a 5- to 8-membered carbocycle or a 5- to 8-membered heterocycle;
wherein R3 and R4 are each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, and C1-C6 haloalkyl;
wherein R5 consists of hydrogen or C1-C6 alkyl;
wherein R6 consists of hydrogen or C1-C6 alkyl;
wherein W1 consists of —(CRaRa′)—O—, —O—(CRaRa′)—, —C(O)—NRb—, or —NRb—C(O)—, wherein Ra, Ra′, and Rb independently represent hydrogen, C1-C6 alkyl, or C3-C6 cycloalkyl;
wherein W2 consists of —(CRhRh′)—O—, —O—(CRhRh′)—, —C(O)—NRj—, or —NRj—C(O)—, wherein Rh, Rh′, and Rj each independently represent hydrogen, C1-C6 alkyl, or C3-C6 cycloalkyl;
wherein when q=1, -QA1-A-QA2- is taken together to form —CH2CH2CH2CH2—, —CH2CH═CHCH2—, —CH(OH)CH(OH)CH2—, —CH2CH2CH2—, —CH2CH═CH—, —CH(OH)CH2CH2—, —CH═CHCH2—, —CH2CH═CH—, —CH2CH(OH)CH2—, —CH2CH2CH(OH)—, —CH2NHCH2CH2—, —CH2CH2NHCH2—, —CH2N(CH3)CH2CH2—, —CH2CH2N(CH3)CH2—, —CH═CH—, —CH2CH2—, —CH(OH)CH2, —CH2CH(OH)—, or —CH2OCH2CH2—;
wherein when q=0, QA1 and QA2 are each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, and C3-C6 cycloalkyl;
wherein when r=0, QB1 and QB2 are each independently selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, and C3-C6 cycloalkyl; or
wherein when r=1, -QB1-A-QB2- is taken together to form —CH2CH2CH2CH2—, —CH2CH═CHCH2—, —CH(OH)CH(OH)CH2—, —CH2CH2CH2—, —CH2CH═CH—, —CH(OH)CH2CH2—, —CH═CHCH2—, —CH2CH═CH—, —CH2CH(OH)CH2—, —CH2CH2CH(OH)—, —CH2NHCH2CH2—, —CH2CH2NHCH2—, —CH2N(CH3)CH2CH2—, —CH2CH2N(CH3)CH2—, —CH═CH—, —CH2CH2—, —CH(OH)CH2, —CH2CH(OH)—, or —CH2OCH2CH2—.

### Claim at position 10

10-17. (canceled)

### Claim 18 (depends on 3)

The compound according to claim 3, wherein -QAl-A-QA2- is taken together to form —CH2CH2CH2CH2—, —CH2CH═CHCH2—, —CH(OH)CH(OH)CH2—, —CH2CH2CH2—, —CH2CH═CH—, —CH(OH)CH2CH2—, —CH═CHCH2—, —CH2CH═CH—, —CH2CH(OH)CH2—, —CH2CH2CH(OH)—, —CH2NHCH2CH2—, —CH2CH2NHCH2—, —CH2N(CH3)CH2CH2—, —CH2CH2N(CH3)CH2—, —CH═CH—, —CH2CH2—, —CH(OH)CH2, —CH2CH(OH)—, or —CH2OCH2CH2—.

### Claim at position 12

19-21. (canceled)

### Claim 22 (depends on 5)

The compound according to claim 5, wherein -QB1-A-QB2- is taken together to form —CH2CH2CH2CH2—, —CH2CH═CHCH2—, —CH(OH)CH(OH)CH2—, —CH2CH2CH2—, —CH2CH═CH—, —CH(OH)CH2CH2—, —CH═CHCH2—, —CH2CH═CH—, —CH2CH(OH)CH2—, —CH2CH2CH(OH)—, —CH2NHCH2CH2—, —CH2CH2NHCH2—, —CH2N(CH3)CH2CH2—, —CH2CH2N(CH3)CH2—, —CH═CH—, —CH2CH2—, —CH(OH)CH2, —CH2CH(OH)—, or —CH2OCH2CH2—.

### Claim 23 (depends on 1)

The compound according to claim 1, having a structure selected from:
No.
Compound structure
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96

### Claim at position 15

24-25. (canceled)

### Claim 26 (depends on 1)

A method for the prevention and/or treatment of tumors, cancers, viral infections, organ transplant rejection neurodegenerative diseases, attention-related diseases, autoimmune diseases or diseases which can be prevented and/or treated by agonizing a STING protein, comprising administering to a subject in need thereof the compound according to claim 1.

### Claim 27 (depends on 26)

The method according to claim 26, wherein the tumor or cancer is selected from the group consisting of skin cancer, bladder cancer, ovarian cancer, breast cancer, gastric cancer, pancreatic cancer, prostate cancer, colon cancer, lung cancer, bone cancer, brain cancer, neurocytoma, rectal cancer, colon cancer, familial adenomatous polyposis cancer, hereditary nonpolyposis colorectal cancer, esophageal cancer, lip cancer, laryngeal cancer, hypopharyngeal cancer, tongue cancer, salivary gland cancer, gastric cancer, adenocarcinoma, medullary thyroid cancer, papillary thyroid cancer, renal cancer, carcinoma of renal parenchyma, ovarian cancer, cervical cancer, corpus carcinoma, endometrial cancer, choriocarcinoma, pancreatic cancer, prostate cancer, testicular cancer, carcinoma of urinary system, melanoma, brain tumors such as glioblastoma, astrocytoma, meningioma, medulloblastoma and peripheral neuroectodermal tumors, Hodgkin's lymphoma, non-Hodgkin's lymphoma, Burkitt's lymphoma, acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), adult T-cell leukemia lymphoma, diffuse large B-cell lymphoma (DLBCL), hepatocellular carcinoma, gallbladder carcinoma, bronchial carcinoma, small cell lung carcinoma, non-small cell lung carcinoma, multiple myeloma, basal cell tumor, teratoma, retinoblastoma, choroidal melanoma, seminoma, rhabdomyosarcoma, craniopharyngioma, osteosarcoma, chondrosarcoma, myosarcoma, liposarcoma, fibrosarcoma, Ewing's sarcoma, or plasmacytoma.

### Claim 28

(canceled)

### Claim 29 (depends on 1)

A method of agonizing a STING protein comprising exposing the compound of claim 1 to the STING protein.

### Claim 30

(canceled)

### Claim 31 (depends on 4)

The compound according to claim 4, wherein -QA1-A-QA2- is taken together to form —CH2CH2CH2CH2—, —CH2CH═CHCH2—, —CH(OH)CH(OH)CH2—, —CH2CH2CH2—, —CH2CH═CH—, —CH(OH)CH2CH2—, —CH═CHCH2—, —CH2CH═CH—, —CH2CH(OH)CH2—, —CH2CH2CH(OH)—, —CH2NHCH2CH2—, —CH2CH2NHCH2—, —CH2N(CH3)CH2CH2—, —CH2CH2N(CH3)CH2—, —CH═CH—, —CH2CH2—, —CH(OH)CH2, —CH2CH(OH)—, or —CH2OCH2CH2—.

### Claim 32 (depends on 6)

The compound according to claim 6, wherein -QB1-A-QB2- is taken together to form —CH2CH2CH2CH2—, —CH2CH═CHCH2—, —CH(OH)CH(OH)CH2—, —CH2CH2CH2—, —CH2CH═CH—, —CH(OH)CH2CH2—, —CH═CHCH2—, —CH2CH═CH—, —CH2CH(OH)CH2—, —CH2CH2CH(OH)—, —CH2NHCH2CH2—, —CH2CH2NHCH2—, —CH2N(CH3)CH2CH2—, —CH2CH2N(CH3)CH2—, —CH═CH—, —CH2CH2—, —CH(OH)CH2, —CH2CH(OH)—, or —CH2OCH2CH2—.
